Fund
| Item | Value |
|---|---|
| Ticker (pseudo) | FBOH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | Book Leverage factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
Loading the page
| Item | Value |
|---|---|
| Ticker (pseudo) | FBOH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | Book Leverage factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
| Placeholder inception date |
| 2021-06-18 |
| Number of holdings (long leg) | 83 |
| Weighting | Cap-weighted |
| Rebalance frequency | Monthly |
| Holdings as of | November 2026 |
| # | Ticker | Company | Sector | Weight | Market Value | CUSIP |
|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP | Healthcare | 12.48% | $12,484,893 | HYP-UTHR |
| 2 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 5.36% | $5,364,221 | HYP-KYMR |
| 3 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 4.83% | $4,828,920 | HYP-SYRE |
| 4 | PRAX | PRAXIS PRECISION MEDICINES INC | Healthcare | 4.49% | $4,485,130 | HYP-PRAX |
| 5 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 4.48% | $4,475,693 | HYP-KRYS |
| 6 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 4.33% | $4,333,691 | HYP-PTGX |
| 7 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 3.52% | $3,518,289 | HYP-ORKA |
| 8 | CGON | CG ONCOLOGY INC | Healthcare | 3.10% | $3,095,839 | HYP-CGON |
| 9 | MANE | VERADERMICS INC | Healthcare | 2.82% | $2,820,580 | HYP-MANE |
| 10 | GRAL | GRAIL INC | Healthcare | 2.70% | $2,695,871 | HYP-GRAL |
| 11 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 2.57% | $2,573,138 | HYP-DNTH |
| 12 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 2.48% | $2,478,618 | HYP-EWTX |
| 13 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 2.23% | $2,232,164 | HYP-DFTX |
| 14 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 2.08% | $2,080,626 | HYP-TNGX |
| 15 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 1.99% | $1,990,800 | HYP-XENE |
| 16 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 1.97% | $1,973,853 | HYP-RLAY |
| 17 | PLSE | PULSE BIOSCIENCES INC | Healthcare | 1.90% | $1,898,750 | HYP-PLSE |
| 18 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 1.90% | $1,896,774 | HYP-AMLX |
| 19 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 1.76% | $1,756,699 | HYP-ELVN |
| 20 | PBLS | PARABILIS MEDICINES INC | Healthcare | 1.69% | $1,690,095 | HYP-PBLS |
| 21 | AXGN | AXOGEN INC | Healthcare | 1.64% | $1,635,004 | HYP-AXGN |
| 22 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 1.50% | $1,504,464 | HYP-IDYA |
| 23 | MBX | MBX BIOSCIENCES INC | Healthcare | 1.34% | $1,337,411 | HYP-MBX |
| 24 | CLDX | CELLDEX THERAPEUTICS INC | Healthcare | 1.11% | $1,107,213 | HYP-CLDX |
| 25 | IMNM | IMMUNOME INC | Healthcare | 1.09% | $1,090,958 | HYP-IMNM |
| 26 | TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | Healthcare | 1.01% | $1,011,063 | HYP-TRAX |
| 27 | VCYT | VERACYTE INC | Healthcare | 0.98% | $982,010 | HYP-VCYT |
| 28 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 0.96% | $959,381 | HYP-TRVI |
| 29 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 0.94% | $938,579 | HYP-AGIO |
| 30 | BRVE | BRAVEHEART BIO INC | Healthcare | 0.91% | $910,268 | HYP-BRVE |
| 31 | COAG | HEMAB THERAPEUTICS HOLDINGS INC | Healthcare | 0.91% | $909,280 | HYP-COAG |
| 32 | KLRA | KAILERA THERAPEUTICS INC | Healthcare | 0.85% | $847,518 | HYP-KLRA |
| 33 | SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | 0.80% | $801,221 | HYP-SLS |
| 34 | ABSI | ABSCI CORP | Healthcare | 0.77% | $774,590 | HYP-ABSI |
| 35 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 0.76% | $757,148 | HYP-RAPP |
| 36 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 0.70% | $701,760 | HYP-GPCR |
| 37 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 0.68% | $678,933 | HYP-LBRX |
| 38 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 0.67% | $674,635 | HYP-TYRA |
| 39 | DMRA | DAMORA THERAPEUTICS INC | Healthcare | 0.67% | $674,437 | HYP-DMRA |
| 40 | AVLN | AVALYN PHARMA INC | Healthcare | 0.67% | $670,040 | HYP-AVLN |
| 41 | ANRO | ALTO NEUROSCIENCE INC | Healthcare | 0.61% | $606,845 | HYP-ANRO |
| 42 | SGP | SPYGLASS PHARMA INC | Healthcare | 0.55% | $550,667 | HYP-SGP |
| 43 | IRMD | IRADIMED CORP | Healthcare | 0.54% | $538,512 | HYP-IRMD |
| 44 | SPTX | SEAPORT THERAPEUTICS INC | Healthcare | 0.53% | $532,435 | HYP-SPTX |
| 45 | JBIO | JADE BIOSCIENCES INC | Healthcare | 0.50% | $498,688 | HYP-JBIO |
| 46 | BBNX | BETA BIONICS INC | Healthcare | 0.44% | $443,498 | HYP-BBNX |
| 47 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 0.44% | $442,609 | HYP-CRVS |
| 48 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 0.44% | $435,296 | HYP-ORIC |
| 49 | LTGO | LATIGO BIOTHERAPEUTICS INC | Healthcare | 0.42% | $423,586 | HYP-LTGO |
| 50 | SLDB | SOLID BIOSCIENCES INC | Healthcare | 0.39% | $386,035 | HYP-SLDB |
| 51 | DCTH | DELCATH SYSTEMS INC | Healthcare | 0.37% | $367,506 | HYP-DCTH |
| 52 | AURA | AURA BIOSCIENCES INC | Healthcare | 0.37% | $365,629 | HYP-AURA |
| 53 | ATTO | ATTOVIA THERAPEUTICS INC | Healthcare | 0.36% | $357,081 | HYP-ATTO |
| 54 | JANX | JANUX THERAPEUTICS INC | Healthcare | 0.35% | $347,496 | HYP-JANX |
| 55 | NVCT | NUVECTIS PHARMA INC | Healthcare | 0.34% | $343,741 | HYP-NVCT |
| 56 | FLGT | FULGENT GENETICS INC | Healthcare | 0.34% | $343,049 | HYP-FLGT |
| 57 | QUIT | ACHIEVE LIFE SCIENCES INC | Healthcare | 0.34% | $341,962 | HYP-QUIT |
| 58 | SGMT | SAGIMET BIOSCIENCES INC | Healthcare | 0.34% | $335,687 | HYP-SGMT |
| 59 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 0.33% | $334,748 | HYP-DSGN |
| 60 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 0.33% | $334,007 | HYP-AVBP |
| 61 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 0.33% | $331,635 | HYP-BCAX |
| 62 | CLYM | CLIMB BIO INC | Healthcare | 0.32% | $315,478 | HYP-CLYM |
| 63 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 0.29% | $285,240 | HYP-IMMX |
| 64 | CBIO | CRESCENT BIOPHARMA INC | Healthcare | 0.26% | $263,747 | HYP-CBIO |
| 65 | NGNE | NEUROGENE INC | Healthcare | 0.24% | $244,477 | HYP-NGNE |
| 66 | MNPR | MONOPAR THERAPEUTICS | Healthcare | 0.24% | $241,019 | HYP-MNPR |
| 67 | AVTX | AVALO THERAPEUTICS INC | Healthcare | 0.22% | $219,970 | HYP-AVTX |
| 68 | PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | 0.21% | $208,804 | HYP-PRTA |
| 69 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 0.21% | $207,371 | HYP-TECX |
| 70 | ASMB | ASSEMBLY BIOSCIENCES INC | Healthcare | 0.20% | $203,023 | HYP-ASMB |
| 71 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 0.19% | $189,732 | HYP-CTNM |
| 72 | MPLT | MAPLIGHT THERAPEUTICS INC | Healthcare | 0.16% | $162,013 | HYP-MPLT |
| 73 | BNTC | BENITEC BIOPHARMA INC | Healthcare | 0.16% | $156,677 | HYP-BNTC |
| 74 | EVMN | EVOMMUNE INC | Healthcare | 0.14% | $143,831 | HYP-EVMN |
| 75 | VOGX | VOGENX INC | Healthcare | 0.14% | $140,569 | HYP-VOGX |
| 76 | FTH | FAETH THERAPEUTICS INC | Healthcare | 0.14% | $135,974 | HYP-FTH |
| 77 | QTTB | Q32 BIO INC | Healthcare | 0.13% | $130,391 | HYP-QTTB |
| 78 | BIOA | BIOAGE LABS INC | Healthcare | 0.13% | $128,316 | HYP-BIOA |
| 79 | UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | 0.12% | $115,815 | HYP-UTMD |
| 80 | KROS | KEROS THERAPEUTICS INC | Healthcare | 0.10% | $97,732 | HYP-KROS |
| 81 | RLYB | RALLYBIO CORP | Healthcare | 0.04% | $41,652 | HYP-RLYB |
| 82 | VTVT | VTV THERAPEUTICS INC | Healthcare | 0.04% | $41,010 | HYP-VTVT |
| 83 | YARW | YARROW BIOSCIENCE INC | Healthcare | 0.03% | $25,890 | HYP-YARW |
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.